Last checked at 2 Oct 2017 07:00
NetScientific plc
("NetScientific" or the "Company" or the "Group")
Wanda Awarded US Patent which Extends Protection across the US
London, UK - October 2nd 2017 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the U.S. Patent and Trademark Office of a new patent exclusively licensed to its portfolio company, Wanda. The patent will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management. The patent, titled, "Context-aware prediction in medical systems" is among the technologies developed at UCLA which aim to better assess and predict medical events by defining and using contextual data on top of medical information.
Commenting on the news, NetScientific's Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: "We are delighted to announce this strengthening of the IP landscape for Wanda, which represents an important step for Wanda's organisational development. We believe Wanda's class leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector."
NetScientific holds a 61% stake on a fully diluted basis in Wanda.
For more information, please contact:
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO | Tel: +44 (0)20 3514 1800 |
Consilium Strategic Communications Mary-Jane Elliott Jessica Hodgson / Chris Welsh / Laura Thornton
|
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
Stifel Nicolaus Europe Limited (NOMAD and Broker) Jonathan Senior / David Arch / Ben Maddison | Tel: +44 (0) 20 7710 7600 |
About NetScientific
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
About Wanda
San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.